Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-12-14FDA Approved: RAYALDEE — Supplemental Application (OPKO Pharmaceuticals LLC)
FDA approved a supplemental application for RAYALDEE (calcifediol) from OPKO Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Glycaemic Response to Oral Nutrition Support During Haemodialysis [NA]
This completed clinical trial evaluates glycaemic response to oral nutrition support during haemodialysis in individuals with diabetes and k…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Contrast Media Reduction and Removal in Patients With Chronic Kidney Disease (CKD) (PRESERV) [NA]
The PRESERV trial evaluating reduction and removal of contrast media in patients with chronic kidney disease was terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects [Phase 1]
Phase 1 pharmacokinetic comparison of CKD-501 in subjects with renal impairment versus healthy controls to assess the impact of kidney funct…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Vascular Reactivity in Chronic Kidney Disease (CKD) Patients Receiving Paricalcitol Versus Placebo [NA]
A completed clinical trial comparing vascular reactivity in chronic kidney disease patients treated with paricalcitol versus placebo; result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Comparison of Effectiveness and Safety of Three Lock Solutions for Long-Term Central Venous Catheter for Hemodialysis [Phase 4]
A Phase 4 trial comparing the effectiveness and safety of three lock solutions used for long-term central venous catheters in patients under…
-
FDA label_change · 2016-12-01FDA Approved: VELTASSA — Supplemental Application (Vifor Pharma, Inc.)
The FDA approved a supplemental application for VelTassa (patiromer) submitted by Vifor Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Clinical Trial on the Use of 25-OH -D Vitamin in Haemodialysis Patients [Phase 3]
A Phase 3 clinical trial evaluating the use of 25-hydroxyvitamin D in haemodialysis patients has been terminated.
-
FDA label_change · 2016-11-30FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for ZEMPLAR (paricalcitol) to update labeling and/or indications.
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Renal Effects of Meditarranean Diet and Low-protein Diet With Ketoacids on Physiological Intestinal Mibrobiota in CKD [Phase 4]
Phase 4 clinical trial evaluating whether a Mediterranean diet and a low-protein diet with ketoacids affect gut microbiota in chronic kidney…
-
FDA approval · 2016-11-25FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Sevelamer carbonate (Renvela) from Sanofi-Aventis U.S. LLC, updating the product labeling. The c…
-
FDA approval · 2016-11-25FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for sevelamer carbonate (Renvela) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Interdialytic Kt/V Variability Measurement With Adimea (IVP STUDY)
Clinical trial update announcing the completion of a study measuring interdialytic Kt/V variability using the Adimea device in dialysis pati…
-
CLINICAL_TRIALS research · 2016-11-22Clinical Trial Update: Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD) [Phase 2]
A Phase 2 clinical trial evaluating the combination of rituximab and mesenchymal stem cells for nephrotic syndrome in patients with chronic …
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions [NA]
A completed clinical trial evaluating strategies to prevent contrast-induced nephropathy in patients with chronic kidney disease undergoing …
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Effects of a Walking Intervention in Older Patients With Chronic Kidney Disease: Feasibility Study [NA]
A completed feasibility trial evaluating the feasibility of a walking program for older adults with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: Early Identification and Action in CKD [NA]
A completed clinical trial investigating early identification and action strategies in chronic kidney disease and hypertension.
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: Study to Determine Appropriate Nurse: Patient Ratios in Peritoneal Dialysis Programs
This clinical trial aimed to determine the appropriate nurse-to-patient ratios in peritoneal dialysis programs and has completed.
-
FDA approval · 2016-11-09FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Ferric Citrate submitted by Mylan Pharmaceuticals Inc., adding regulatory authorization for the …
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)
Post-market observation study PROVIDE evaluating intra-renal drug delivery by Angiodynamics has been terminated; the record notes the trial …
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: A Study of Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis. [Phase 3]
A Phase 3 study assessing subcutaneous C.E.R.A. (methoxy polyethylene glycol-epoetin beta) for maintaining hemoglobin levels in adults with …
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis
A Roche-sponsored completed trial update reporting results from a survey of anemia therapy in participants with chronic kidney disease not o…
-
CLINICAL_TRIALS research · 2016-11-04Clinical Trial Update: A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant [Phase 4]
Phase 4 trial evaluating subcutaneous mircera versus no ESA therapy for anemia in patients with chronic kidney disease after kidney transpla…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of extended-release and immediate-release febuxostat in patients with gout and moderate r…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction? [Phase 4]
Phase 4 trial evaluating whether xanthine oxidase inhibitors can reduce left ventricular hypertrophy and improve endothelial function in pat…